Head-to-head · Cost-Efficiency Index
Blue Haven RX vs Healthicare
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Blue Haven RX
Shoppers who read the FAQ carefully before trusting the homepage price.
Visit Blue Haven RXHealthicare
Shoppers who want every line item of the price shown before checkout, in 44 states.
Visit HealthicareThe verdict
Blue Haven RX and Healthicare tie on the Cost-Efficiency Index at 61/100, so neither wins outright on the numbers. For most shoppers we'd start with Blue Haven RX (ranked #225, a hair above #228) — Shoppers who read the FAQ carefully before trusting the homepage price. But Healthicare is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Blue Haven RX.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Blue Haven RX | Healthicare |
|---|---|---|
| Cost-Efficiency Index | 61/100 | 61/100 |
| Semaglutide / mo | $149/mo (all doses, compounded) | $174/mo (all doses, plus a separate fee, compounded) |
| Tirzepatide / mo | $179/mo (all doses, compounded) | $264/mo (all doses, compounded) |
| Semaglutide / yr (modeled) | $1,788 | $2,088 |
| Tirzepatide / yr (modeled) | $2,148 | $3,168 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #225 | #228 |
Blue Haven RX
61/100Where the value is
- Claims flat, dose-independent pricing ('no price increases' regardless of dose)
- Routes to established physician networks (Wasef Health, Beluga Health) rather than an unknown in-house provider
- Payments held until doctor approval, per site copy, reducing risk of paying for a declined prescription
The tradeoffs
- Internal pricing contradiction: homepage says tirzepatide is $179/month, FAQ says $259/month
- No named medical director
Healthicare
61/100Where the value is
- Every component of the price is itemized on-page — medication, consult, prep, shipping, platform fee, and service fee are each individually listed rather than bundled into one opaque number
- Named medical director (Dr. Jonah Mink, Beluga Health) and named compounding pharmacy (Jungle Jim's Pharmacy/F&F Pharmacies, Fairfield, OH) with phone numbers for both
- No membership fee, same medication price regardless of dose, and 'cancel anytime, no commitments'
The tradeoffs
- Explicitly excluded from 10 states — CA, NV, NJ, NC, TX, MA, MS, NH, WV, DE — due to the pharmacy's dispensing license
- Brand-name first-month pricing ($1,199.99+) is at or above cash retail; the compounded tier is the only competitive option
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.